Does NFAT1 partner with other transcription factors in the absence of AP-1?
Enrichment for AP-1 motifs. Somewhat surprisingly, isolated AP-1 consensus sites (5'-TGA G / C TCA-3') were strongly enriched, both in endogenous NFAT1 ChIP-seq peaks and in CA-RIT-NFAT1 ChIP-seq peaks in stimulated cells ( Figure 4C, 4D) . We suspected that a minimal 5'-GG-3' or 5'-GGA-3' sequence with the correct spacing (5 , relative to the first T of the AP-1 site) might be sufficient to nucleate endogenous NFAT binding but not CA-RIT-NFAT1 binding at these sites. Indeed, further inspection showed that 11% of the "AP-1 only" sites identified in NFAT1 ChIP-seq peaks contained the doublet GG at -8 and -7, compared to only 5% and 6% of resting and stimulated CA-RIT-NFAT1 peaks respectively; similarly, 3% of the "AP-1 only" sites identified in NFAT1 ChIP-seq peaks contained the triplet 5'-GGA-3' at -8, -7 and -6, compared to 0.8% and 1% of resting and stimulated CA-RIT-NFAT1 peaks (Table S7) . This difference is strongly significant, indicating that AP-1 motifs within endogenous NFAT1 ChIP-seq peaks are considerably more likely than AP-1 motifs identified within CA-RIT-NFAT1 peaks to have correctly-spaced degenerate NFAT sites in the vicinity. That is, a considerable fraction of the apparently isolated AP-1 sites found in NFAT1 ChIP-seq peaks actually represent composite NFAT:AP-1 sites, in which a strong consensus AP-1 site is positioned with the correct spacing next to a weak degenerate NFAT site. However, some of these isolated AP-1 sites (either in NFAT1 or CA-RIT-NFAT1 ChIP-seq peaks) may represent independent binding of NFAT, AP-1 and other transcription factors to nucleosome-depleted regions that assemble "enhanceosomes" (Carey, 1998) .
Enrichment for STAT motifs. ChIP-seq peaks that bound CA-RIT-NFAT1 but not endogenous NFAT1 were enriched for sequence motifs annotated as STAT binding sites ( Figure 4D ). The enriched motifs had the sequence 5'-TTC C / T n A / G GAA-3', a subset of the 5'-TTCnnn[n]GAA-3' motif of conventional STAT sites . One explanation was that these sequences bound bonafide STAT proteins, activated because of the cytokines present in our culture conditions. However, their enrichment in ChIP-seq peaks for CA-RIT-NFAT1 but not endogenous NFAT1 binding argued against the simple explanation that STAT and NFAT proteins bound together to nucleosome-free regions in an "enhanceosome" context, and led us to test whether palindromic TTCC nGGAA sequences could accommodate a dimer of two NFAT1 DNA-binding domains oriented with the alignment ß à (an orientation opposite to that of NFAT1 dimers crystallized on NFκB-like sites (à ß) [5'-AGGAATTTCC-3' (Jin et al., 2003) ; 5'-GGGACTTTCC-3' (Giffin et al., 2003; Hogan et al., 2003) ]. Indeed, electrophoretic mobility shift assays (EMSA) confirmed that a recombinant NFAT1 DNAbinding domain (DBD) (Chen et al., 1998) bound at low concentrations to the IL-2 promoter NFAT:AP-1 site as a monomer, at moderate concentrations to a palindromic κB-like site as a homodimer (Giffin et al., 2003; SotoNieves et al., 2009) , and at high concentrations to a 5'-TTCCAGGAA-3' sequence (that would also be expected to bind STAT dimers) as a homodimer (data not shown). The binding of NFAT to STAT-like DNA elements was recently confirmed through SELEX experiments using recombinant NFAT2 DNA-binding domain (Jolma et al., 2010; Jolma et al., 2013) . While we cannot at present determine whether NFAT actually binds the 5'-TTCC nGGAA-3' subset of "STAT" sites in intact nuclei, these sequence motifs potentially represent novel binding sites for NFAT proteins in the absence of AP-1.
Potential role of BATF proteins in CD8 + T cell exhaustion.
A previous publication showed, in the context of chronic HIV infection, that the PD-1-PDL1 interaction led to upregulation of the transcription factor BATF, and that BATF expression inhibited T cell function (Quigley et al., 2010) . These authors suggest that BATF/Jun complexes act downstream of PD-1 induction, in a signaling step that occurs subsequent to PD-1:PD-L1 interaction (Quigley et al., 2010) . However because BATF is a basic region-leucine zipper (bZIP) protein that belongs to the same family of transcription factors as AP-1 (Fos-Jun), we asked whether NFAT1 could physically or functionally interact with BATF. We overexpressed HA-tagged NFAT1 or CA-RIT-NFAT1, Flagtagged BATF, Flag-tagged JunB and His-tagged IRF4 in HEK293 T cells, and performed electrophoretic mobility shift assays (EMSA) with individual or mixed extracts and the composite NFAT:AP-1 site from the IL-2 promoter (ARRE-2 region) as probe.
We found that NFAT1 formed a cooperative complex with BATF/JunB, whereas CA-RIT-NFAT1 did not (data not shown), implying (i) that BATF proteins might indeed exert biological effects in CD8 + T cells through cooperative binding with NFAT and Jun proteins on certain NFAT:AP-1 composite sites, and (ii) that mutation of the Fos-Jun interaction interface in NFAT1 also disrupted NFAT1 interaction with BATF-Jun as expected. However, comparing our data for NFAT1 and published ChIP-seq data for BATF (Kurachi et al., 2014) 
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Retroviral transduction
Murine NFAT1 and its mutants were cloned into an MSCV-based vector that expresses GFP from an IRES sequence. The NFAT1 mutants were (i) CA-NFAT1, encoding a constitutively active (CA) NFAT1 with alanine substitutions at 12 phosphorylated serine residues in the regulatory domain (Okamura et al., 2000) , (ii) CA-RIT-NFAT1, in which the 12 S>A mutations in the NFAT1 regulatory domain that render NFAT1 constitutively active and the R468A/I469A/T535G that abrogates AP-1 binding are combined (Macian et al., 2002) , and (iii) DBDmut-CA-RIT-NFAT1, which codes for CA-RIT-NFAT1 with an R423A/Y426A/E429A/G430A mutation in the DNA binding loop that abrogates DNA binding (Chen et al., 1998; Jain et al., 1995) .
shRNA targeting CD4 or NFAT4 was obtained from the mouse pGIPZ lentiviral library (Open Biosystems), and subcloned into the JSB45 retroviral vector kindly provided by Dr. James Scott-Browne (LIAI), which encodes Ametrine (a variant of GFP) driven by the MSCV LTR and the shRNA sequence in the context of the miR30 backbone. The sequences of shCD4 and shNFAT4 are: priming, the culture medium was replaced with virus supplemented with 8 µg/ml polybrene. The plates were centrifuged at 2,000 rpm for 1 h at 30 °C and then incubated at 37 °C for 3-4 h. Then, the medium was replaced with the original media removed before addition of virus. For shRNA transduction, this process was repeated on day 2. On day 2, cells were removed from stimulus, and expanded with IL-2 (10 or 100 U/ml for CD8 + T cells (Pipkin et al., 2010) and 20 U/ml for CD4 + T cells). On day 4-6 after activation, GFP + or Ametrine + cells were purified by FACS, and re-stimulated in the presence or absence of PMA and ionomycin for 6 h.
Isolation and culture of T cells
Spleen and lymph nodes were harvested from 6-to 8-week-old mice. Naïve CD8 + or CD4 + (CD25 lo , CD44 lo , CD62L hi ) T cells were purified (>95% purity) by negative selection (Invitrogen) from RBC-lysed single-cell suspensions from pooled spleen and lymph node cells (for TCR transgenic mice) or by fluorescence-activated cell sorting (FACS; for non-TCR transgenic mice). For stimulation, purified CD4 + or CD8 + T cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, penicillin-streptomycin, non-essential amino acids, sodium pyruvate, vitamins, 10 mM HEPES, and 50 µM 2-mercaptoethanol. Cells were plated at 10 6 cells/ml in 6-well plates coated with anti-CD3
(clone 2C11) and anti-CD28 (clone 37.51) (1 µg/ml each) by pre-coating with 100 µg/ml goat anti-hamster IgG (Cappel). After 48 h, cells were removed from the TCR signal and re-cultured at a concentration of 5x10 5 cells/ml in media supplemented with 10 or 100 U/ml recombinant human IL-2 (rhIL-2) as indicated, to generate 'memory' and 'effector' CD8 + CTL respectively (Pipkin et al., 2010) , or 20 U/ml rhIL-2 for CD4 + T cells. Every 24 h, cells were counted and readjusted to 5x10 5 cells/ml with fresh media containing rhIL-2. On day 6, cells were either left untreated (resting), or re-stimulated with phorbol 12-myristate 13-acetate (PMA; 15 nM; Sigma) and ionomycin (1 or 0.5 µM; Sigma) or anti-CD3 and anti-CD28 for 6 h. Expression of cell surface receptors and cytokine production were assessed by flow cytometry.
For analysis of cytokine production, Brefeldin A (1 µg/ml, Sigma) was added during the last two hours of stimulation with PMA and ionomycin. Restimulated cells were harvested, washed in PBS, fixed in 2% paraformaldehyde, washed again in PBS and then permeabilized with 0.5% saponin in PBS supplemented with 1% FBS (saponin staining buffer). Permeabilized cells were stained in saponin staining buffer using labeled αIL-2 (JES6-5H4), αIFN-γ (XMG1.2) and αTNF (MP6-XT22) antibodies from Biolegend. Stained cells were washed in saponin staining buffer before finally resuspending with PBS/1.0% FBS for flow cytometric analysis, performed on Fortessa (BD Biosciences).
Western blots for TCR signaling
Naïve CD8 + T cells were stimulated with anti-CD3 and anti-CD28, transduced with empty vector (Mock) or CA-RIT-NFAT1 as indicated above. GFP + CD8 + T cells were purified by FACS, rested on ice for 2 h, and incubated with anti-CD3 and anti-CD28 for 30 min on ice. Anti-hamster IgG was added at different time points to induce TCR signaling, protein extracts were prepared with Lysis Buffer (50 mM Tris pH 7.5, 150 mM NaCl, 10% glycerol, 5 mM EDTA, 1% Nonidet-P40 and protease inhibitors (Sigma)) and immunoblot analysis was performed with the indicated antibodies after SDS-PAGE in 4-12% gradient gels. The following antibodies were used: anti-phospho-PLCγ1 (Tyr783) antibody (Cat 2821P, Cell Signaling), anti-phospho-ZAP70 (Tyr319)/Syk (Tyr352) antibody (Cat 2701, Cell Signaling), anti-PLCγ1 antibody (sc-81, Santa Cruz Biotechnologies), antiActin antibody (Cat A1978, Sigma).
Calcium influx measurements
Naïve CD4 + T cells were stimulated with anti-CD3 and anti-CD28, transduced with empty vector (Mock) or CA-RIT-NFAT1 as indicated above, and analyzed four days after activation. For flow cytometric measurements of calcium influx, the cells were loaded with 1 µM Fluo-4-AM and 1 µM FuraRed for 30 min at room temperature, then washed and incubated with biotinylated anti-CD3 at 4°C for 15 min. After washing, baseline calcium measurements were collected, and then streptavidin was added for TCR crosslinking. Ionomycin was used as a positive control for activation of store-operated calcium entry. For single-cell Ca 2+ imaging, the cells were loaded with 3 µM fura-2/AM (Molecular Probes) for 30-45 min at room temperature in DMEM containing 10 mM HEPES, washed twice with fresh media, and loaded on coverslips coated with poly-L-ornithine. Cells were perfused with 0 Ca solution (containing EGTA) and rested for 10-15 min before starting the experiment, and analysed as previously described (Sharma et al., 2013) . 100 mock-transduced cells, and 40-50 CA-RIT-NFAT1-transduced cells were imaged. Mean and standard deviation are plotted in Figure S1G .
Quantitative Real-time RT-PCR
Total RNA was prepared using TRIzol reagent (Invitrogen) from T cells purified by FACS. cDNA was synthesized using Superscript reverse transcriptase and oligo(dT) primers (Invitrogen), and gene expression was examined with
Step One Plus (Applied Biosystems) using Roche SYBR green real-time master. Gene expression was normalized to Rpl32 (encodes L32 ribosomal protein) gene expression. 
RNA-seq sample preparation
Naïve CD4 + or CD8 + T cells were activated and transduced as previously indicated, and total RNA was extracted using Qiagen RNeasy kit. For RNA-seq analysis, 50 µg of total RNA was used to isolate poly(A) RNA using the micropoly(A)purist kit (Ambion). The whole transcriptome library kit (Life Technologies) was used to prepare paired-end sequencing libraries. Briefly, 150 ng of poly(A) + RNA was enzymatically fragmented to an average size of 150 nt, ligated to directional adapters and reverse-transcribed, and the cDNA was size-selected on denaturing 6% TBE-Urea polyacrylamide gels, amplified for 15 cycles with barcoded primers and purified using AmpPure XP beads. The resulting libraries were quantified using Bioanalyzer (Agilent) and Taqman (Life Technologies) assays. Barcoded libraries from each sample were combined at equimolar amounts and the mixture was used at a final concentration of 0.4 pM in emulsion PCR to link the libraries to the sequencing beads. The samples were sequenced on a single slide. The number of total and mappable reads is shown in Table S4A .
RNA-seq data analysis
The sequencing reads in color-space were mapped to the mm9 genome using Tophat and exon-exon junctions were derived from the RefSeq gene annotations downloaded on June 16, 2012 (Pruitt et al., 2012) . The number of reads falling into each gene defined in the RefSeq gene annotations was quantified using HTSeq-count (Anders and Huber, 2010) . The DESeq software (Anders and Huber, 2010 ) was used to detect differentially expressed genes (p adj <0.01 or p<0.05) between any pair of biological conditions. The RPKM values were calculated based on the read counts using a custom script. Tables S4B and S4C show the RPKM values for each gene in CD4 + and CD8 + T cells, respectively. Sequencing was performed using a SOLID4 sequencer (Applied Biosystems).
The previously published Gata3 (GSM523211,GSM523212, GSM661237,GSM661238) (Wei et al., 2011) , Tbx21 (GSM994537,GSM994538) (Vahedi et al., 2012) , Stat4 (GSM994535,GSM994536) (Vahedi et al., 2012) , Stat6 (GSM994539,GSM994540) (Vahedi et al., 2012) , Rorc (GSE40918) (Ciofani et al., 2012) , Batf (GSE40918) (Ciofani et al., 2012) , Irf4 (GSE40918) (Ciofani et al., 2012) and Stat3 (GSE40918) (Ciofani et al., 2012) RNA-seq data sets (obtained by comparing T cells from gene-disrupted mice with wild type controls) were downloaded from GEO and used in Figure S4E . The accession codes are given in the parentheses. Differentially expressed genes in Rorc, Irf4 and Stat3 gene-disrupted mice were detected using the provided DESeq output files (p<0.05). Due to the lack of biological replicates, genes were considered to be differentially expressed upon Gata3, Tbx21, Stat4 and Stat6 deletion if they were expressed (RPKM>1) at least in one of the conditions (wild-type or knockout) and their expression showed at least two fold-change between the conditions (wild-type versus knockout).
For Figure 2C , middle and right panels show genes differentially expressed only in CD4 + (middle) or CD8 + T cells (right) upon CA-RIT-NFAT1 transduction, ordered by gene expression and shown next to the same genes in CD8 + and CD4 + T cells respectively; for these latter genes, the change in expression did not reach statistical significance, but was color-coded according to the fold change observed.
Microarray data analysis
The CD4 + CD25 -CD45RB low LAG3 + and CD4 + CD25 -CD45RB low LAG3 -microarray data (Okamura et al., 2009) were downloaded from the ArrayExpress database deposited under the accession code E-MEXP-1343. The microarray data were processed using the robust multi-array average (RMA) algorithm (Irizarry et al., 2003) , quantile-normalized (Bioconductor affy package) and log2-transformed. Due to the lack of biological replicates, genes were considered to be differentially expressed if their expression was changed by at least two fold between the conditions. We compared our data with the previously published data from naïve, exhausted, effector and memory T cells CD8 + T cells reported in (Wherry et al., 2007) . The genes belonging to the reported clusters were extracted. The genes, i.e., gene symbols, not found from the current RefSeq annotations were discarded. If a given gene symbol was reported multiple times within a cluster it was considered only once. In both cases, the comparison with the genes identified from the RNA-seq data was done using the gene names. The Fisher's exact test was used for testing statistical significances of the observed overlaps, that is, to calculate the probability of observing as extreme or more extreme overlap between two randomly selected gene sets.
Chromatin immunoprecipitation (ChIP)
CD8 + P14 + Tcra -/-WT or NFAT1-deficient cells were stimulated and transduced with either empty vector (Mock) or vector expressing CA-RIT-NFAT1, as indicated above, and GFP + cells were purified by FACS-sorting. Cells were either left untreated (resting), or restimulated with PMA and ionomycin for 1 h. Then, cells were fixed for 10 min using fixation solution (1.1% formaldehyde, 10 mM NaCl, 0.1 mM EDTA, 50 µM EGTA, 5 mM HEPES) at RT at 1x10 6 cells/ml. Fixation was stopped with 120 mM glycine on ice for 5 min. Fixed cells were washed 2X with cold PBS, 1X with cold Solution I (10 mM Tris pH 7.5, 10 mM EDTA, 0.5 mM EGTA, 1% TritonX-100) and 1X with cold Solution II (10 mM Tris pH 7.5, 1mM EDTA, 0.5 mM EGTA, 200 mM NaCl). After washes, cell pellets were resuspended at 20-40x10 6 /ml in RIPA buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA, 1%
NP-40, 0.1% SDS, 0.5% Deoxycholate plus protease and phosphatase inhibitors). Chromatin (40 x10 6 cell equivalents) was sheared with a Bioruptor and further sonicated with Covaris to yield 100-300 bp DNA fragments. After pre-clearing the sheared chromatin with protein G Dynabeads and removing 5% as input DNA, immunoprecipitation was performed by adding protein G and anti-NFAT1 antibody complexes (50 µl protein G Dynabeads were incubated with 7.5 µg of anti-NFAT1 antibodies against the N-terminal 67.1 peptide, (Wu et al., 2006) for 6 h, then washed with RIPA buffer and incubated with chromatin), followed by overnight incubation at 4°C. Beads were then washed 2X with RIPA buffer, 1X with High Salt buffer (50 mM Tris pH 8.0, 500 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS) and 1X with TE. After the last wash, DNA was eluted by resuspending the beads in Elution Buffer (1% SDS, 100 mM NaHCO3). Both input and ChIP DNA were then treated with RNase A (5 µg total) for 1 h at 37°C, followed by addition of Proteinase K (5 µg total) and overnight incubation at 65°C to reverse crosslinking. DNA was then purified with QIAquick columns (QIAGEN Gel Extraction Kit) per manufacturer's instructions and resuspended in a 45 µl volume.
ChIP-seq library preparation
Immunoprecipitated and de-crosslinked DNA was quantified using Qubit (Invitrogen), and 2-5 ng of DNA were utilized for library preparation. Briefly, DNA was end-repaired using DNA Terminator End Repair kit (Lucigene Cat No 40037-2) to make DNA ends ligatable. Repaired DNA ends were ligated with the Quick Ligase Kit (New England Biolabs cat. no M2200L) to SOLID P2 and custom barcoded SOLID P1 adaptors for multiplexing. Ligated products were precipitated and separated on 6% native TBE polyacrylamide gels, and fragments corresponding to 150-300 bp were excised. Excised gel slices were further cut into four pieces, and PCR was performed directly on gel slices using Phusion High Fidelity Polymerase (NEB Cat no M0531L) using PCR primers as indicated by Applied Biosystems. Primer dimers were removed using two rounds of Ampure XP beads cleanup. DNA was then quantified using Bioanalyzer (Agilent) and Taqman assay as indicated by Applied Biosystems. Barcoded libraries from each sample were combined at equimolar amounts and the mixture was used at a final concentration of 0.4 pM in emulsion PCR to link the libraries to the sequencing beads. Sequencing was performed using a SOLID4 sequencer (Applied Biosystems).
ChIP-seq data analysis
Sequencing reads were assigned to specific samples based on perfect matches to the custom barcodes. Reads were mapped using Bowtie (Langmead et al., 2009 ) to the mm9 genome in color-space, using default parameters. Reads with identical sequences were filtered and only one was retained for subsequent analysis.
The number of total and mappable reads is shown in Table S5A . Fragment size estimation and NFAT1 binding detection relative to input DNA were done using HOMER (Heinz et al., 2010) with the default parameter settings. The binding sites detected in NFAT1-deficient cells transduced with empty vector (Mock) were assumed to be nonspecific. The binding sites detected in the other samples that overlapped by at least 1 bp with the nonspecific binding sites were removed from the subsequent analysis. Peak locations in the genome are listed in Table S5B . The differential NFAT1 binding sites present in WT cells stimulated with PMA and ionomycin but not in CA-RIT-NFAT1-expressing cells, or vice-versa are shown in Tables S3A-C.
The previously published GATA3 (GSM523226) (Wei et al., 2011) , TBX21 (GSM836124) (Nakayamada et al., 2011) , STAT4 (GSM550303) , STAT6 (GSM550311) , RORC (GSM1004855,GSM1005009) (Ciofani et al., 2012) , BATF (GSM1004787,GSM1005017) (Ciofani et al., 2012) , IRF4 (GSM1004831,GSM1005004) (Ciofani et al., 2012) and STAT3 (GSM1004860,GSM1005005) (Ciofani et al., 2012) ChIP-seq data were downloaded from GEO. The accession codes are given in the parentheses. The provided GATA3, TBX21, STAT4 and STAT6 binding site sets were used. The binding of RORC, BATF, IRF4 and STAT3 against input DNA were detected using HOMER with the default parameter settings. Note that IRF4 and BATF ChIP-seq data from (Ciofani et al., 2012) were used only in Figure S4E .
Motif enrichment analysis
A motif enrichment analysis for a given set of genomic regions was done using HOMER (Heinz et al., 2010) with the mm9 genome, default parameters, and the default collection of 171 known binding motifs.
Identification of degenerate NFAT:AP-1 composite motifs
AP-1 and NFAT:AP-1 composite motifs were identified within the binding sites using HOMER (Heinz et al., 2010) . AP-1 motif positions overlapping with the NFAT:AP-1 composite motif were discarded from subsequent analysis. The sequences around the AP-1 motif positions (+/-15 nt) were extracted ( Table S7 ). The frequencies of the nucleotide pair 5'-GG-3' (-8,-7) and triplet 5'-GGA-3' (-8,-7,-6) relative to the first T of the AP-1 motif in the WT PMA/Iono, CA-RIT-NFAT1 resting and CA-RIT-NFAT1 PMA/iono samples were calculated ( Table S7 ). The statistical significance of the differences in the proportions was assessed using the two-proportion z test (two-tailed) ( Table S7) .
Analysis of NFAT1 ChIP-seq peaks in CA-RIT-NFAT1-regulated genes
In generating Figure 3E -F, for a given gene, the distances from all the annotated transcription start sites (RefSeq) to the closest CA-RIT-NFAT1 binding site in resting NFAT1-deficient cells transduced with CA-RIT-NFAT1 were calculated and the shortest distance was taken into account in the subsequent analysis. In Figure  3E the cumulative distributions of the calculated distances for separate gene sets are plotted, whereas in Figure 3F , the probability mass functions are plotted.
In generating Figure S4B -D, the CA-RIT-NFAT1 IP signals measured using ChIP-seq in resting and restimulated NFAT1-deficient cells transduced with CA-RIT-NFAT1 were quantified using the RPM metric in the vicinity (± 500 bp) of all the detected CA-RIT-NFAT1 binding sites located either at promoters or first introns in restimulated NFAT1-deficient cells transduced with CA-RIT-NFAT1. In Figure S4B , the IP signals across all the binding sites are depicted. The rows (binding sites) in Figure S4B are in the descending order based on the CA-RIT-NFAT1 IP signals at the centers of the binding sites in restimulated NFAT1-deficient cells transduced with CA-RIT-NFAT1. Figure S4C depicts the average IP signals calculated over the binding sites depicted in Figure S4B . The boxplots in Figure S4D represent the NFAT1 IP signal values at the centers of the binding sites. Statistical significance of the observed difference in the medians of the groups in Figure S4D was assessed using the Wilcoxon signed-rank test.
